NasdaqGS - Nasdaq Real Time Price USD

Pliant Therapeutics, Inc. (PLRX)

1.3800
-0.0900
(-6.12%)
At close: May 13 at 4:00:01 PM EDT
1.4100
+0.03
+(2.17%)
After hours: May 13 at 5:33:53 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
1,580
9,685
7,572
Operating Expense
234,908
228,365
185,725
136,885
105,107
Operating Income
-234,908
-228,365
-184,145
-127,200
-97,535
Net Non Operating Interest Income Expense
15,393
18,061
22,809
3,879
272
Pretax Income
-219,515
-210,304
-161,336
-123,321
-97,263
Net Income Common Stockholders
-219,515
-210,304
-161,336
-123,321
-97,263
Diluted NI Available to Com Stockholders
-219,515
-210,304
-161,336
-123,321
-97,263
Basic EPS
-3.61
-3.47
-2.75
-2.94
-2.71
Diluted EPS
-3.61
-3.47
-2.75
-2.94
-2.71
Basic Average Shares
60,799.0780
60,538.6390
58,719.0830
42,015.9080
35,846.4210
Diluted Average Shares
60,799.0780
60,538.6390
58,719.0830
42,015.9080
35,846.4210
Total Operating Income as Reported
-234,908
-228,365
-184,145
-127,200
-97,535
Total Expenses
234,908
228,365
185,725
136,885
105,107
Net Income from Continuing & Discontinued Operation
-219,515
-210,304
-161,336
-123,321
-97,263
Normalized Income
-219,515
-210,304
-161,336
-123,321
-97,263
Interest Income
18,771
21,085
24,076
4,670
272
Interest Expense
3,378
3,024
1,267
791
0
Net Interest Income
15,393
18,061
22,809
3,879
272
EBIT
-216,137
-207,280
-160,069
-122,530
-97,263
EBITDA
-214,077
-205,155
-158,228
-120,707
-95,728
Reconciled Depreciation
2,060
2,125
1,841
1,823
1,535
Net Income from Continuing Operation Net Minority Interest
-219,515
-210,304
-161,336
-123,321
-97,263
Normalized EBITDA
-214,077
-205,155
-158,228
-120,707
-95,728
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/3/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZNTL Zentalis Pharmaceuticals, Inc.
1.2100
-6.20%
 
CGEM Cullinan Therapeutics, Inc.
7.62
-3.67%
 
RAPT RAPT Therapeutics, Inc.
0.7479
-14.90%
 
STOK Stoke Therapeutics, Inc.
8.93
-7.56%
 
ALXO ALX Oncology Holdings Inc.
0.4810
+10.52%
 
VOR Vor Biopharma Inc.
0.1600
-7.25%
 
ACRV Acrivon Therapeutics, Inc.
1.1300
-5.83%
 
RVMD Revolution Medicines, Inc.
39.95
-4.61%
 
OLMA Olema Pharmaceuticals, Inc.
4.6800
-1.68%
 
NKTX Nkarta, Inc.
1.9400
-3.96%